BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30802692)

  • 1. Molecular mechanisms of immunoreceptors in platelets.
    Kuriri FA; O'Malley CJ; Jackson DE
    Thromb Res; 2019 Apr; 176():108-114. PubMed ID: 30802692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
    Lee RH; Bergmeier W
    J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet integrins and immunoreceptors.
    Kasirer-Friede A; Kahn ML; Shattil SJ
    Immunol Rev; 2007 Aug; 218():247-64. PubMed ID: 17624957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
    Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
    Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity.
    Boulaftali Y; Hess PR; Kahn ML; Bergmeier W
    Circ Res; 2014 Mar; 114(7):1174-84. PubMed ID: 24677237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITIM receptors: more than just inhibitors of platelet activation.
    Coxon CH; Geer MJ; Senis YA
    Blood; 2017 Jun; 129(26):3407-3418. PubMed ID: 28465343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation studies with anti-CD41/61 monoclonal antibodies.
    Mateo A; Perez de la Lastra JM; Garrido JJ; Llanes D
    Vet Immunol Immunopathol; 1996 Aug; 52(4):357-62. PubMed ID: 8896225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the porcine homologue to human platelet glycoprotein IIb-IIIa (CD41/CD61) by a monoclonal antibody.
    Pérez de la Lastra JM; Moreno A; Pérez J; Llanes D
    Tissue Antigens; 1997 Jun; 49(6):588-94. PubMed ID: 9234480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The negative regulation of platelet function: extending the role of the ITIM.
    Gibbins JM
    Trends Cardiovasc Med; 2002 Jul; 12(5):213-9. PubMed ID: 12161075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet antigens CD9, CD42 and integrin alpha IIb beta IIIa can be topographically associated and transduce functionally similar signals.
    Slupsky JR; Kamiguti AS; Rhodes NP; Cawley JC; Shaw AR; Zuzel M
    Eur J Biochem; 1997 Feb; 244(1):168-75. PubMed ID: 9063461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway.
    Stegner D; Haining EJ; Nieswandt B
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1615-20. PubMed ID: 24925975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
    Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
    Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice.
    Gowert NS; Klier M; Reich M; Reusswig F; Donner L; Keitel V; Häussinger D; Elvers M
    Cell Physiol Biochem; 2017; 41(6):2133-2149. PubMed ID: 28441661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
    Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
    Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function.
    Moriarty R; McManus CA; Lambert M; Tilley T; Devocelle M; Brennan M; Kerrigan SW; Cox D
    Thromb Haemost; 2015 Feb; 113(2):290-304. PubMed ID: 25413489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of monoclonal antibodies to murine platelet glycoprotein IIb/IIIa (alphaIIbbeta3) and other proteins from hamster-mouse interspecies hybridomas.
    Lengweiler S; Smyth SS; Jirouskova M; Scudder LE; Park H; Moran T; Coller BS
    Biochem Biophys Res Commun; 1999 Aug; 262(1):167-73. PubMed ID: 10448087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
    Phillips DR; Nannizzi-Alaimo L; Prasad KS
    Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4.
    Arman M; Krauel K; Tilley DO; Weber C; Cox D; Greinacher A; Kerrigan SW; Watson SP
    Blood; 2014 May; 123(20):3166-74. PubMed ID: 24642751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
    Gupta S; Braun A; Morowski M; Premsler T; Bender M; Nagy Z; Sickmann A; Hermanns HM; Bösl M; Nieswandt B
    Circ Res; 2012 Nov; 111(11):1410-20. PubMed ID: 22955732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.